The Glucagon-like peptide-1 (GLP1) drugs are set to be the star performers for insulin drug makers across the globe as the menace of diabetes and obesity is in line to rise exponentially in the years to come. GLP1 drugs are medications which have traditionally been used to treat type 2 diabetes and more recently for obesity. The pharma majors making GLP1 drugs globally are racing to get their drugs on the shelves with the demand for these drugs outstripping the supply in many markets. GLP1 drugs have become highly recommended due to their diverse treatment profile which is effective in lowering sugar levels, reducing obesity and providing cardiovascular risk benefits.We caught up with John C. Dawber, CVP and MD, Global Business Services, Novo Nordisk to know about the company’s growth story and much more.
Since your company is one of the leading drug makers in GLP1 medicines, how are you viewing the market growth rate here in India and globally?
Globally the GLP1 market was growing at a rate of 60 per cent in 2022 and we see it continuing to grow at a similar pace going forward. This has happened due to the benefits of these particular groups of medicines, which control blood glucose for people with diabetes and also reduce weight. And some of those molecules have evidence to show prevention of other complications of diabetes such as a heart attack and cardiovascular complications.
This story is from the August 12, 2023 edition of BW Businessworld.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the August 12, 2023 edition of BW Businessworld.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Powerful, Peculiar Perquisites
MOST COMPANIES recognise that people are key to their success. Competition is all about the war for talent. Higher compensations can, in many cases, attract that brilliant leader or the tech genius, but a competitor may well offer even more. This race is financially draining and not really a great strategy.
Shaping The Future Of India's Infrastructure
RUPEN PATEL on the achievements of the engineering and construction major including the iconic projects rendered by it, nation building, focus on sustainable practices and much more
WHY DON'T WE SUE BRITAIN?
I WAS WORKING ON my next column for BW – on one of my favourite themes like ‘Sustainability’, ‘Inclusivity’, ‘India Shining’ etc.
LIFE AND TIMES OF A MEDIA TITAN
DD Purkayastha's autobiography captures his 42-year tryst with the ABP Group, delving into various aspects of his professional and personal experiences, as well as insights into the factors that have shaped his character and career trajectory
THE SONET STRIKES BACK
The sub-4-metre SUV segment in India has been a battlefield for automakers, each vying for supremacy with their unique propositions. With the launch of 2024 Kia Sonet, the South Korean automaker is sharpening its edges in this competitive market
SLEEK, SUBTLE, COMPACT AND EASY TO CARRY
The HP Omen Transcend 14 targets a niche market that is growing day by day. Statistically, never in history, was there a better time to launch a gaming laptop, says Deep Majumdar
Geopolitical Resilience for Indian Companies
It's in crisis that inventiveness is born, as well as discoveries made and great strategies arise. He who overcomes crisis, overcomes himself, without getting overcome. - Albert Einstein
The Sourav Ganguly Era
Lessons in Leadership from Indian Cricket - 2
Leadership Challenges Were Not This Long, Before
LEADING IN TODAY’S dynamic environment presents unprecedented challenges. The list of challenges is never-ending. They include navigating complex decisions, staying resilient, inspiring teams, staying innovative, and continually adapting to the constantly changing ecosystem.
The Supreme Court Emerges as a Net Zero Polestar
'Dharma exists for the welfare of all beings. Hence, that by which the welfare of all living beings is sustained, that for sure is dharma,' - Mahabharata (Shanti Parva 109.10)